Syndicated Research Studies

Diabetes Associated Ophthalmic Treatment Industry Overview The global diabetes associated ophthalmic treatment market size was valued at USD 27.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2028. The factors influencing the market growth include the increasing prevalence of type II diabetes, the growing geriatric population, rising incidences of vision loss due to excess diabetic condition, increasing awareness regarding ophthalmic disorders, and inclination towards early diagnosis. Furthermore, advancements in technology have resulted in the invention of new and safer products to treat diabetes associated ophthalmic diseases. However, the lack of skilled ophthalmologists and the longer duration of drug approvals are expected to hinder the market growth. Gather more insights about the market drivers, restrains and growth of the Global Diabetes Associated Ophthalmic Treatment Market An increase in the incidence of diabetes...